Bank Of America Corp Crispr Therapeutics Ag Put Options Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2025 Aug 14, 2025	BUY	$31.27 - $48.64 $7.94 Million - $12.4 Million	254,000 New	254,000 $12.4 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $728,040 - $1.07 Million	12,000 Added 31.58%	50,000 $3.41 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $973,223 - $1.82 Million	25,200 Added 196.88%	38,000 $2.38 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $556,416 - $867,456	12,800 New	12,800 $718,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $11.9 Million - $16.3 Million	194,600 Added 40.23%	678,300 $44.3 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $20.9 Million - $35.7 Million	483,600 Added 483600.0%	483,700 $29.4 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $5.78 Million - $8.61 Million	-108,600 Reduced 99.91%	100 $6,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $22.9 Million - $36.4 Million	-326,900 Reduced 75.05%	108,700 $8.24 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $23.2 Million - $33 Million	210,800 Added 93.77%	435,600 $48.8 Million
Q2 2021 Sep 13, 2021	BUY	$100.84 - $161.89 $22.7 Million - $36.4 Million	224,800 New	224,800 $36.4 Million

525

69.6M

3.72M

2.33M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.42B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.